Related Experiment Video

Updated: Feb 18, 2026

Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique
09:37

Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique

Published on: September 23, 2022

2.3K

Urticarial vasculitis after meningococcal serogroup B vaccine in a 6-year-old girl

Virginia Velasco-Tamariz1, Marta Prieto-Barrios1, Fátima Tous-Romero1

  • 1Department of Dermatology, Hospital 12 de Octubre, Madrid, Spain.

Pediatric Dermatology
|November 23, 2017
PubMed

Insights

A new vaccine for serogroup B meningococcal disease may be linked to urticarial vasculitis, a rare condition in children. Further investigation is needed to confirm this potential adverse event and ensure vaccine safety.

Area of Science:

  • Pediatrics
  • Immunology
  • Dermatology

Background:

  • A novel vaccine for serogroup B meningococcal disease (MenB) has been approved, offering broad protection.
  • Post-marketing surveillance is crucial for identifying potential adverse events associated with new vaccines.

Observation:

  • This report details a rare case of urticarial vasculitis in a child.
  • The child developed symptoms following vaccination with the novel MenB vaccine.

Findings:

  • The observed urticarial vasculitis is a rare condition in pediatric patients.
  • A probable relationship between the novel MenB vaccine and the development of urticarial vasculitis is suggested.

Implications:

  • This case highlights the importance of monitoring for rare adverse events following vaccination.
  • Further research is warranted to establish causality and assess the risk-benefit profile of the new vaccine.
  • Clinicians should be aware of this potential adverse event when administering the MenB vaccine.

Keywords:
meningococcal B vaccineurticarial vasculitis

More Related Videos

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts07:50

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

Published on: September 20, 2018

16.5K
A Suction Blister Protocol to Study Human T-cell Recall Responses In Vivo11:17

A Suction Blister Protocol to Study Human T-cell Recall Responses In Vivo

Published on: August 11, 2018

12.6K

Related Concept Videos

Hypersensitivity Reactions: Immune-Complex Reactions01:19

Hypersensitivity Reactions: Immune-Complex Reactions

Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum...
22
Hypersensitivity Reactions: Cytolytic Reactions01:01

Hypersensitivity Reactions: Cytolytic Reactions

Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
21
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions01:29

Hypersensitivity Reactions: Delayed Hypersensitivity Reactions

Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
27
Vaccinations01:51

Vaccinations

Overview
52.0K
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
22
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
575